SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro
| Autor: | Hsu, AC-Y, Wang, G, Reid, AT, Veerati, PC, Pathinayake, PS, Daly, K, Mayall, JR, Hansbro, PM, Horvat, JC, Wang, F, Wark, PA |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|